API

Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.

The role of glyphosate

Glyphosate is a biocide herbicide developed by the famous American company Monsanto.

Mar 21,2022  API

Toxicity of Garenoxacin

Garenoxacin is a desfluoro quinolone which, as such, lacks a fluorine at the C-6 position in comparison with other fluoroquinolones, such as ciprofloxacin, moxifloxacin, and levofloxacin, and has a di

Mar 18,2022  API

Toxicity of Gatifloxacin

Gatifloxacin is an 8-methoxy fluoroquinolone and is marketed by Bristol Myers Squibb as Tequint. Three formulations are available: oral, ophthalmic, and intravenous. Like other members of this class,

Mar 18,2022  API

The steroid antibiotics---?Fusidic acid

Fusidic acid was developed by Leo Laboratories in Copenhagen and obtained from the fungus Fusidium coccineum.

Mar 18,2022  API

What is Fosfomycin?

Fosfomycin is a phosphoenolpyruvate analogue produced by Streptomyces fradiae and by some Pseudomonas spp., but is now mostly obtained synthetically. It is a broad-spectrum antibiotic with bactericida

Mar 18,2022  API

Ampicillin–Sulbactam: Antimicrobial Activity, Susceptibility, Administration and Dosage, Clinical Uses etc.

Ampicillin–sulbactam (AMP/S) is a beta-lactam/beta-lactamase inhibitor that was developed to overcome the increasing resistance of various bacteria to ampicillin. AMP/S is marketed under various trad

Mar 18,2022  API

Instructions of ?Pristinamycin

?Pristinamycin is a mixture of water-insoluble pristinamycin IA (PIA, 90–97%) and pristinamycin IIA (PIIA, 3–10%), derived from S. pristinaespiralis.

Mar 18,2022  API

Linezolid:U-100766

Linezolid (previously U-100766) is the first in a new class of completely synthetic antimicrobial agents, the oxazolidinones.

Mar 18,2022  API

The first glycylcycline---Tigecycline

Tigecycline is produced by Wyeth under the trade name of Tygacils. The modification of the tetracycline nucleus led to a reduction in tetracycline-specific efflux and ribosomal protection.

Mar 18,2022  API

Amoxicillin–clavulanic acid: Clinical Uses and Toxicity

Co-amoxiclav is widely used with good cure rates to treat urinary tract infections caused by both beta-lactamase-producing and nonproducing organisms, although in the latter case there is no advantage

Mar 18,2022  API
Prev12345678910...Next>  Go to Page